A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studies
- PMID: 30664659
- PMCID: PMC6341122
- DOI: 10.1038/s41467-018-08166-x
A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studies
Abstract
Comprehensive preclinical studies of Myelodysplastic Syndromes (MDS) have been elusive due to limited ability of MDS stem cells to engraft current immunodeficient murine hosts. Here we report a MDS patient-derived xenotransplantation model in cytokine-humanized immunodeficient "MISTRG" mice that provides efficient and faithful disease representation across all MDS subtypes. MISTRG MDS patient-derived xenografts (PDX) reproduce patients' dysplastic morphology with multi-lineage representation, including erythro- and megakaryopoiesis. MISTRG MDS-PDX replicate the original sample's genetic complexity and can be propagated via serial transplantation. MISTRG MDS-PDX demonstrate the cytotoxic and differentiation potential of targeted therapeutics providing superior readouts of drug mechanism of action and therapeutic efficacy. Physiologic humanization of the hematopoietic stem cell niche proves critical to MDS stem cell propagation and function in vivo. The MISTRG MDS-PDX model opens novel avenues of research and long-awaited opportunities in MDS research.
Conflict of interest statement
The authors declare no competing interests.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6341122/bin/41467_2018_8166_Fig1_HTML.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6341122/bin/41467_2018_8166_Fig2_HTML.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6341122/bin/41467_2018_8166_Fig3_HTML.gif)
![Fig. 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6341122/bin/41467_2018_8166_Fig4_HTML.gif)
![Fig. 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6341122/bin/41467_2018_8166_Fig5_HTML.gif)
![Fig. 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6341122/bin/41467_2018_8166_Fig6_HTML.gif)
Similar articles
-
Humanized three-dimensional scaffold xenotransplantation models for myelodysplastic syndromes.Exp Hematol. 2022 Mar;107:38-50. doi: 10.1016/j.exphem.2021.12.395. Epub 2021 Dec 22. Exp Hematol. 2022. PMID: 34952140
-
Humanized mice as preclinical models for myeloid malignancies.Biochem Pharmacol. 2020 Apr;174:113794. doi: 10.1016/j.bcp.2020.113794. Epub 2020 Jan 10. Biochem Pharmacol. 2020. PMID: 31926939 Review.
-
Bone marrow niche in the myelodysplastic syndromes.Leuk Res. 2015 Oct;39(10):1020-7. doi: 10.1016/j.leukres.2015.06.017. Epub 2015 Jul 14. Leuk Res. 2015. PMID: 26276090 Review.
-
Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit.Cell Stem Cell. 2014 Jun 5;14(6):824-37. doi: 10.1016/j.stem.2014.02.014. Epub 2014 Apr 3. Cell Stem Cell. 2014. PMID: 24704494
-
Mouse models of myelodysplastic syndromes.Hematol Oncol Clin North Am. 2010 Apr;24(2):361-75. doi: 10.1016/j.hoc.2010.02.002. Hematol Oncol Clin North Am. 2010. PMID: 20359631 Free PMC article. Review.
Cited by
-
The evolution of preclinical models for myelodysplastic neoplasms.Leukemia. 2024 Apr;38(4):683-691. doi: 10.1038/s41375-024-02181-2. Epub 2024 Feb 23. Leukemia. 2024. PMID: 38396286 Free PMC article. Review.
-
Discovery of U2AF1 neoantigens in myeloid neoplasms.J Immunother Cancer. 2023 Dec 12;11(12):e007490. doi: 10.1136/jitc-2023-007490. J Immunother Cancer. 2023. PMID: 38164756 Free PMC article.
-
IL-6 trans-signaling in a humanized mouse model of scleroderma.Proc Natl Acad Sci U S A. 2023 Sep 12;120(37):e2306965120. doi: 10.1073/pnas.2306965120. Epub 2023 Sep 5. Proc Natl Acad Sci U S A. 2023. PMID: 37669366 Free PMC article.
-
Progress in construction of mouse models to investigate the pathogenesis and immune therapy of human hematological malignancy.Front Immunol. 2023 Aug 14;14:1195194. doi: 10.3389/fimmu.2023.1195194. eCollection 2023. Front Immunol. 2023. PMID: 37646021 Free PMC article. Review.
-
Moving low-risk myelodysplastic syndromes from humans to mice: is it truly that simple?Haematologica. 2024 Jan 1;109(1):8-10. doi: 10.3324/haematol.2023.283652. Haematologica. 2024. PMID: 37534538 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous